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Synopsis: Utilising a TLR9-deficient mouse model and the TLR9 antagonist ODN2088, we 
have shown that ammonia-induced brain edema requires macrophage and T cell expression of 
TLR9 supporting exploration of TLR9 antagonism in acute liver failure. 
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Abstract 
Background & Aim: Ammonia is central in the pathogenesis of brain edema in acute liver 
failure (ALF) with infection and systemic inflammation expediting development of 
intracranial hypertension (ICH). Patients with acetaminophen-induced ALF have increased 
neutrophil TLR9 expression which can be induced by ammonia. We determined whether 
ammonia-induced brain edema and immune dysfunction are mediated by TLR9 and if this 
could be prevented in a TLR9-deficient mouse model. 
Methods: Ammonium acetate (NH4-Ac; 4mmol/kg) was injected intraperitoneally in wild 
type (WT), Tlr9-/- and Lysm-Cre Tlr9fl/fl mice (TLR9 absent in neutrophils and macrophages 
including Kupffer cells) and compared to controls. Six hours after NH4-Ac injection, 
intracellular cytokine production was determined in splenic macrophages, CD4+ and CD8+ T 
cells. Brain water (BW) and total plasma DNA (tDNA) were also measured. The impact of 
the TLR9 antagonist ODN2088 (50µg/mouse) was evaluated. 
Results: Following NH4-Ac injection, BW, macrophage and T cell cytokine production 
increased (p<0.0001) in WT but not Tlr9-/- mice (p<0.001). ODN2088 inhibited macrophage 
and T cell cytokine production (p<0.05) and prevented an increase in BW (p<0.0001). 
Following NH4-Ac injection, macrophage cytokine production and BW were ameliorated in 
Lysm-Cre Tlr9fl/fl mice compared to WT mice (p<0.05) but there was no difference compared 
to Tlr9-/- mice. Following NH4-Ac injection, plasma tDNA levels increased in WT and Tlr9-/- 
mice (p<0.05) suggesting that TLR9 may be activated by DNA released from ammonia-
stimulated cells. 
Conclusion: Ammonia-induced brain edema requires macrophage and T cell expression of 
TLR9. Amelioration of brain edema and lymphocyte cytokine production by ODN2088 
supports exploration of TLR9 antagonism in early ALF to prevent progression to ICH. 
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Introduction 
Ammonia plays a pivotal role in the development of hepatic encephalopathy (HE) and brain 
edema in acute liver failure (ALF).1-3 A robust systemic inflammatory response and 
susceptibility to developing infection are common in ALF, exacerbate the development of 
ammonia-induced brain edema and are major prognosticators.4-10 Experimental models have 
unequivocally associated ammonia exposure with astrocyte swelling and brain edema, 
potentiated by proinflammatory cytokines.11-14  
Toll-like receptor 9 (TLR9) is an innate pattern recognition receptor that binds to the CpG 
motif of bacterial and mammalian DNA.15 TLR9 plays an important role in acetaminophen-
induced liver inflammation16 and we recently reported that ammonia along with DNA 
induces neutrophil TLR9 expression in patients with acetaminophen-induced ALF and 
advanced HE.17 Although the evidence base supporting the relationship between ammonia, 
inflammation and brain edema is robust in ALF, there is a paucity of data characterising the 
specific pathogenic mechanisms entailed. We hypothesised that ammonia-induced brain 
edema and immune dysfunction are mediated by TLR9. As TLR9 is necessary for the 
development of acetaminophen-induced acute liver injury in murine models,16 the hypothesis 
could only be tested in a murine model exposed to ammonium acetate (NH4-Ac) without liver 
injury. 
Using an acute hyperammonemic mouse model, we demonstrated that ammonia-induced 
brain edema and immune dysfunction, as measured by increased brain water (BW) content 
and intracellular cytokine production of macrophages and T cells, are mediated through 
TLR9. In mice, hyperammonemia resulted in DNA release and activation of TLR9 inducing 
downstream inflammatory cytokine production. TLR9 in lysozyme expressing cells was 
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critical for the development of brain edema and immune dysfunction. Administration of a 
TLR9 antagonist abrogated inflammation and prevented brain edema. 
Results 
(i) Ammonia-induced brain edema and changes in the liver were dependent on TLR9 
To determine whether TLR9 plays a role in ammonia-induced brain edema, we evaluated the 
BW content of wild type (WT) and Tlr9-/- mice six hours after a single dose of ammonium 
acetate (NH4-Ac, 4 mM) injection [I.P]. Following NH4-Ac stimulation, there was a 
significant increase in the BW content in WT mice compared to controls; which was 
significantly decreased in Tlr9-/- mice compared to WT mice [Figure 1a] indicating that TLR9 
plays an important role in the development of brain edema. To determine whether the 
increased BW content was associated with any changes in the liver, we assessed the 
liver/body weight ratio and liver histopathology after NH4-Ac stimulation. In WT mice, there 
was a significant increase in liver/body weight ratio with evidence of hepatocyte swelling but 
not necrosis (there was no rise in serum aspartate and alanine transaminases), a finding which 
was abrogated in Tlr9-/- mice [Figure 1 b-c]. We hypothesized that DNA released following 
NH4-Ac stimulation can bind to TLR9 resulting in activation of the innate immune system. 
To test our hypothesis, we measured plasma DNA. Total plasma dsDNA levels were 
significantly increased in WT mice and Tlr9-/- mice following NH4-Ac stimulation compared 
to controls, but there was no difference in Tlr9-/- mice compared to WT mice following NH4-
Ac stimulation [Figure 1d]. 
(ii) Ammonia altered the function of macrophages and T cells in a TLR9-dependent 
manner 
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To determine whether systemic inflammation contributed to the ammonia-induced increase in 
BW content through a TLR9-mediated pathway, we measured intracellular cytokine (IFN-
gamma, TNF-alpha and IL-6) production in T cells and macrophages isolated from spleen 
and liver in WT mice and Tlr9-/- mice following NH4-Ac stimulation. There was a significant 
increase in the intracellular cytokines produced by macrophages [Figure 2 a-d] and CD4+ and 
CD8+ T cells [Figure 3 a-f] isolated from the spleen in WT mice following NH4-Ac 
stimulation, compared to controls which was abrogated in Tlr9-/- mice. A similar trend was 
observed in the immune T cells isolated from the liver [Figure 4]. Neutrophil phagocytic 
activity was unaltered following NH4-Ac stimulation [Figure 5]. 
(iii) Ammonia-induced brain edema and inflammation were independent of acetate or 
pH 
Acetate has been reported to influence inflammation in acute alcoholic hepatitis18 and the 
increased toxicity of ammonium salts promotes ammonium gas transfer across the blood 
brain barrier due to the rise in blood pH and the direct effect of alkalinisation.19 Therefore, to 
confirm whether the TLR9-mediated brain edema and inflammation were solely induced by 
ammonia and not by the acetate or changes in pH, an alternate salt of acetate, sodium acetate 
(NaCH3C02) (Na-Ac) was injected in WT mice after adjusting for pH (same as NH4-Ac). Na-
Ac (4 mM) did not alter the BW content, liver bodyweight ratio or intracellular cytokine 
production of various immune cell subsets in WT mice compared to controls unlike NH4-Ac 
[Figure 6 a-f]. These results confirm that the observed ammonia-induced cytokine production 
and brain edema were induced by ammonia per se, and not influenced by acetate and/or pH 
changes. 
(iv) Ammonia-induced brain edema and inflammation were mediated by TLR9 
expressed within lysozyme-expressing cells 
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Our results showed that deletion of TLR9 tempered the pro-inflammatory state and abrogated 
the development of brain edema following ammonia stimulation. To examine the role of 
TLR9 in macrophages, we used Lysm-Cre Tlr9fl/fl mice that have TLR9 specifically deleted in 
lysozyme-expressing cells, namely macrophages and neutrophils20. NH4-Ac (4 mM) was 
therefore injected into Lysm-Cre Tlr9fl/fl mice. Interestingly, we found that BW content, 
liver/body weight ratio, hepatocyte swelling and cytokines produced by macrophages were 
significantly ameliorated in Lysm-Cre Tlr9fl/fl mice compared to WT mice following NH4-Ac 
stimulation but with no difference compared to Tlr9-/- mice [Figure 7 a-g]. There was no 
difference in the total plasma dsDNA levels in Tlr9-/- mice and Lysm-Cre Tlr9fl/fl mice 
compared to WT mice following NH4-Ac stimulation [Figure 7h].  We also tested another 
control mouse strain, Tlr9fl/fl mice (TLR9 is sufficient in all the cell types). As expected, 
Tlr9fl/fl mice were not protected from NH4-Ac induced inflammation compared to Lysm-Cre 
Tlr9fl/fl mice [Figure 8 a-e].  
(v) TLR9 antagonism abrogates ammonia-induced brain edema and inflammation 
Since Tlr9-/- mice were protected against NH4-Ac stimulation, we tested whether an 
antagonist of TLR9 [ODN2088] could inhibit the ammonia-induced pro-inflammatory 
changes and brain edema observed in the WT mice. Administration of ODN2088 (50 
µg/mouse) with NH4-Ac (4 mM) significantly decreased the BW content and liver/body 
weight ratio and ameliorated the hepatocyte swelling [Figure 9 a-c]. Administration of 
ODN2088 did not alter the total plasma DNA levels in WT mice following NH4-Ac 
stimulation but they were increased compared to controls [Figure 9d]. There was also a 
significant reduction in the cytokines produced by macrophages [Figures 9 e-g] and T cells 
[Figure 10 a-f]. 
 
9 
 
Discussion 
In this study, we have demonstrated a novel link between ammonia-induced inflammation 
and the subsequent development of brain edema mediated by TLR9 using different mouse 
models. In addition, we showed that TLR9 expressed by lysozyme-producing cells in mice 
was critical for ammonia-induced brain edema and inflammation to develop. Importantly, we 
also showed that administration of a TLR9 antagonist abrogated the inflammation and 
prevented brain edema supporting therapeutic exploration of TLR9 antagonism in early ALF. 
Ammonia stimulation upregulated the production of the cytokines IFN-gamma, TNF-alpha 
and IL-6 by macrophages and T cells. The observation of increased cytokine production from 
the hepatic infiltrated T cells indicates that the immune response originates from the liver. 
The cytokines IFN-gamma, TNF-alpha and IL-6 produced by T
 
cells are predominantly 
responsible for mediating inflammation within the liver.21-23 In this study ammonia activated 
cytokine production in macrophages indicated that those cells, along with CD4+ and CD8+ T 
cells, are responsible for promoting the proinflammatory environment. It is possible that 
ammonia and systemic inflammation induce brain edema by inducing astrocyte swelling. 
This is supported by the previously published observation that astrocyte swelling can be 
induced when astrocytes are exposed to pro-inflammatory cytokines after being exposed to 
ammonia.11 Though deficiency of TLR9 exacerbates cognitive impairment and severity of 
seizures in the brain,24 it has been demonstrated that activation of TLR9 in microglia and 
astrocytes induces the production of various pro-inflammatory cytokines in response to CpG 
DNA25 and activation of TLR9 in astrocytes leads to synaptic protein loss in the brain in 
chronic hyperglycemia.26 Activation of Tlr9 results in the upregulation of cytokine 
production and increase in the BW content, and the critical role of TLR9 in this mechanism 
has been demonstrated by using genetically modified mice. TLR9 is essential for macrophage 
10 
 
production of TNF-alpha and IL-6 in response to CpG DNA and IFN-gamma produced by 
CD4+ T cells in response to CpG DNA and mycobacteria.15, 27 The observation that ammonia-
induced TLR9 activation induces systemic inflammation and brain edema is well supported 
by recently published studies that show TLR9 induces inflammation in acetaminophen-
induced ALF and non-alcoholic steatohepatitis.16, 20 
Ammonia stimulation increased the total plasma DNA levels in all the different mouse 
models, thereby suggesting that ammonia activates TLR9 through DNA release. In 
acetaminophen-induced ALF, DNA fragments released by apoptotic hepatocytes have been 
shown to be responsible for the activation of TLR9 and induction of systemic 
inflammation.16, 28 These findings support the results of our recent human study, which 
showed profound TLR9 activation in neutrophils in the presence of plasma DNA in patients 
with acetaminophen-induced ALF, systemic inflammation and brain edema17 suggesting that 
TLR9 mediates the ammonia-induced brain edema in a DNA-driven manner. In this study, it 
is not possible to identify the source of the DNA and we can only speculate that non-immune 
cells are the source of DNA. 
TLR9 expressed in the lysozyme-producing cells played an important role in the ammonia-
induced cytokine production of macrophages and brain edema. Marques et al29 recently 
demonstrated that neutrophils are the predominant innate immune cells that sense DNA 
through the TLR9/NF-κB pathway and induce inflammation in the context of acetaminophen 
toxicity. These data are also well supported by the strong correlation demonstrated between 
neutrophil TLR9 expression, ammonia and IL-8 in acetaminophen-induced ALF and the 
abrogation of neutrophil TLR9 upregulation and cytokine production in acetaminophen-
induced ALF plasma by DNAse-I.17  
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Administration of the TLR9 antagonist, ODN2088 abrogated the cytokine production and 
prevented the increase in BW content induced by stimulation of ammonia. These data are 
well supported by the findings of Imaeda et al,16 who in an acetaminophen-induced 
hepatotoxicity model, established that inhibition of TLR9 using ODN2088 and IRS954, a 
TLR7/9 antagonist, downregulated pro-inflammatory cytokine release and reduced mortality. 
The amelioration of brain edema and cytokine production by ODN2088 supports exploration 
of TLR9 antagonism as a therapeutic modality in early ALF to prevent the development of 
brain edema and intracranial hypertension. 
There are pros and cons of using an ammonia-induced murine model of cerebral edema 
without acute liver injury. Some of the best-characterized animal models of cerebral edema 
in ALF include the hepatic devascularized rat30 and pig,31 and the rat with thioacetamide-
induced toxic liver injury.30 Whilst these models develop cerebral edema and exhibit 
intracranial hypertension, the impact of hepatic devascularisation and necrosis bring other 
sequelae including systemic inflammation, bacterial and fungal sepsis and coagulopathy. This 
makes it hard to tease out the specific mechanisms that underpin the development of 
ammonia-induced brain edema per se and how this relates to innate immune dysfunction. 
Furthermore, we know that murine acetaminophen-induced ALF is mediated by TLR9 and 
can be abrogated by a TLR9 antagonist.16 Therefore, we could not utilise an acetaminophen-
induced model of ALF to assess TLR9-mediated cerebral edema in this study and thus chose 
to examine this in a model of ammonia-induced cerebral edema. 
In summary, this study demonstrates that the development of ammonia-induced brain edema 
requires macrophage and T cell expression of TLR9 which may be stimulated by DNA 
release. The importance of TLR9 expressing neutrophils and/or Kupffer cells in the induction 
of brain edema and inflammation was confirmed by the deletion of the TLR9 gene only in 
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lysozyme expressing cells. We have therefore demonstrated that TLR9 is necessary for the 
development of ammonia-induced brain edema.16,29 The observation that systemic 
inflammation and brain edema can be prevented following administration of a TLR9 
antagonist supports the exploration of TLR9 antagonism as a therapeutic modality in early 
ALF to prevent the progression to ICH. 
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Materials and methods 
Animals used for this study 
All the procedures and protocols used in the studies with animals were approved by the 
Institutional Animal Care and Use Committee at Yale University, USA. Four strains of mice 
on C57BL/6 genetic background were used for the experiments. C57BL/6 (wild type, WT) 
were originally obtained from the Jackson Laboratory (Bar Harbor, Maine, USA). The 
original Tlr9-/- and Tlr9fl/fl breeders were kindly provided by Prof Shizuo Akira, Japan15 and 
Prof Mark Shlomchik, University of Pittsburgh, USA20, respectively.  We bred Lysm-Cre 
mice with Tlr9fl/fl mice to generate Lysm-Cre Tlr9fl/fl mice with TLR9 specific deletion in 
lysozyme expressing cells.32 All the mice used in the study were bred and kept at the Yale 
animal facility in specific pathogen free (SPF) conditions with autoclaved food, bedding and 
filtered cage.  The mice were fed on a regular chow diet and on a 12 hour light/dark cycle.  
Male mice (7-9 weeks old) were used in the study. 
Stimulation with ammonium acetate 
To determine whether TLR9 plays a role in brain edema in the mice, ammonium acetate 
(NH4CH3CO2) (NH4-Ac) (4 mmol/kg of bodyweight) was injected intraperitoneally in WT 
mice, Tlr9-/- mice, Lysm-Cre Tlr9fl/fl mice and Tlr9fl/fl mice that were sacrificed 6 hours after 
the injection. The concentration and duration of NH4-Ac used for this experiment was 
optimised in a pilot experiment. Sodium acetate (NaCH3CO2) (Na-Ac) [J.T. Baker, USA] (4 
mmol/kg of bodyweight) was injected intraperitoneally in WT mice to demonstrate that any 
effect was due to ammonia and not the acetate moiety. 
Blood collection and tissue harvesting 
Six hours after the NH4-Ac stimulation, blood was collected from the mice and liver, spleen 
and brain were harvested. Plasma was collected and stored in -80°C. Spleen was 
14 
 
homogenised using rough sides of two grinding slides and red blood cells were lysed by 
hypotonic solution and quickly restored in isotonic PBS. The single suspension of 
splenocytes (106) was stained with monocloncal antibodies (mAbs) conjugated with different 
fluorochromes prior to flow cytometry analysis. Liver tissue was homogenised using a plunge 
through a wire mesh and digested using Collagenase-I and DNAse-I [Sigma Aldrich, USA]. 
Liver infiltrated immune cells were isolated from the homogenised tissue using the density-
gradient Polymorphprep™ solution [Axis Shield, Norway], stained with mAbs and analysed 
using flow cytometry. The entire brain was weighed immediately after sacrifice using an 
electronic balance to determine the wet weight. The brain was then dried in an oven at 100°C 
for 24 hours to obtain the dry weight. The BW content was then calculated according to the 
formula33: 
BW content (%) =  Wet weight – Dry weight x 100 
Wet weight 
Preservation of tissues for histopathological examination 
For histopathological examination, tissues were harvested and stored in 10% formalin at 
room temperature. Specimens were then embedded in paraffin.  Six µM tissue sections were 
then stained with hematoxylin and eosin (H&E) and examined under a light microscope. 
Total DNA estimation 
Total DNA was measured in the plasma samples stored at -80°C using the Quant-iT 
™ PicoGreen® dsDNA quantitation kit (Life Technologies, USA) as detailed previously.20 
TLR9 antagonist injection 
To determine whether an inhibitor of TLR9 offers protection against NH4-Ac stimulation, the 
TLR9 antagonist (ODN2088) [Invivogen, USA] (50 µg/mouse) was injected intraperitoneally 
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in WT mice immediately following NH4-Ac injection. Six hours later, blood was collected 
and organs were harvested as mentioned above. The time and concentration of ODN2088 
were chosen based upon a recently established mouse model of acetaminophen 
hepatotoxicity.16 
Stimulation of intracellular cytokine (ICC) production 
To determine the intracellular cytokine production of mononuclear cells from spleen and 
liver, up to 5.0 x 106 cells per mL were stimulated with phorbol 12-myristate 13-acetate 
(PMA) (50 ng) and ionomycin [Invivogen, USA] (500 pg) in complete media with Golgi plug 
[BD, USA] (1 µL) and incubated at 37°C for 5 hours in the presence of 5% CO2. At the end 
of 5 hours, stimulated cells were washed, stained with fluorochrome conjugated mAbs and 
analysed using flow cytometry. 
Cell staining and flow cytometry 
Up to 1 million (1 x 106) cells were re-suspended in 100 µL of staining buffer and stained 
with different fluorochrome conjugated mAbs in a tube followed by incubation at room 
temperature (RT) in darkness for 30 minutes and the stained cells were washed with PBS.  
For ICC staining, 100 µL of cytofix/cytoperm solution [BD, USA] was added to the cell 
pellet after staining with surface markers and kept at RT for 20 minutes. The cells were 
washed with 1 mL of permeabilization wash buffer [BD, USA] followed by re-suspension in 
300 µL of PBS and acquired in a LSRII flow cytometry [BD, San Jose, California, USA] 
using BD FACS DIVA software V6.0 [BD, San Jose, California, USA]. 
Neutrophil phagocytosis 
The phagocytic ability of neutrophils was determined by incubating the whole blood with 
Dextran FITC (1mg/mL) at 37°C for 20 minutes in a water bath and measuring the mean 
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fluorescence intensity of the neutrophils in a flow cytometer. Neutrophils were identified 
using Lys6-G (1A8) and CD11b (M1/70) antibodies.  
Identification and characterization of various immune cell subsets 
The different subsets of lymphocytes were identified using their specific markers. T cells 
were identified using CD3 (17A2); CD4 (GK1.5) and CD8 (53-6.7) markers were used to 
characterise the different subsets of T cells and macrophages were identified using F4/80 
(BM8) and CD11b (M1/70) markers. ICC production [IL-6 (MP5-20F3), IFN-gamma 
(XMG1.2) and TNF-alpha (MP6-XT22)] was determined in the CD4+ and CD8+ T cell 
subsets and F4/80+ and CD11b+ macrophages. Flow cytometry antibodies were purchased 
from Biolegend, USA. 
Statistics 
For comparisons between two groups, Student’s t-test (parametric data) or Mann-Whitney U 
test (non-parametric data) were used; for comparisons between three or more groups, One-
way ANOVA with Tukey’s multiple comparison tests (parametric data) or Kruskal Wallis 
with Dunn’s multiple comparison tests (non-parametric data) were used based on the normal 
distribution of the data. All the results are presented as mean or median differences with 95% 
confidence intervals (C.I.). Hypothesis testing was two-tailed at an alpha level 0.05. All 
statistical analyses were performed using GraphPad Prism 7.0; p<0.05 was considered as 
statistically significant. 
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Figure Legend 
Figure – 1: TLR9 stimulates ammonia-induced brain edema and liver bodyweight ratio 
through DNA. 
(a) Following NH4-Ac stimulation, there was a significant increase in the BW content in WT 
mice (n=9) compared to controls (n=12) (p<0.0001) [mean difference: 1.35; 95% C.I.: 0.9 to 
1.8], which was ameliorated in Tlr9-/- mice (n=10) (p=0.006) [mean difference: -0.76; 95% 
C.I.: -1.3 to -0.25]. (b) Following NH4-Ac stimulation, there was a significant increase in the 
liver bodyweight ratio in WT mice (n=16) compared to controls (n=13) (p<0.0001) [mean 
difference: 0.019; 95% C.I.: 0.013 to 0.024], which was ameliorated in Tlr9-/- mice (n=11) 
(p<0.0001) [mean difference: -0.014; 95% C.I.: -0.019 to -0.009]. (c) Following NH4-Ac 
stimulation, there was a significant increase in the hepatocyte swelling in the liver histology 
(H&E stained – 200x magnifications) in WT mice compared to controls, where the cytoplasm 
of cells remained intact. Following NH4-Ac stimulation, there was no difference in the 
hepatocyte morphology in Tlr9-/- mice compared to controls but the hepatocyte swelling was 
reduced compared to WT mice. The images in the black box inset are the representative 
images at 400x magnification. (d) Following NH4-Ac stimulation, there was a significant 
increase in the total plasma DNA level in WT mice (n=12) compared to controls (n=12) 
(p=0.007) [mean difference: 2.97; 95% C.I.: 0.88 to 5] and in Tlr9-/- mice (n=17) compared to 
controls (n=14) (p=0.004) [mean difference: 1.76; 95% C.I.: 0.6 to 2.9]. 
Figure 2: Ammonia-induced intracellular cytokine production by macrophages is mediated 
by TLR9. 
(a) Following NH4-Ac stimulation, there was a significant increase in the intracellular 
cytokine IFN-gamma produced by splenic macrophages in WT mice (n=8) compared to 
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controls (n=7) (p<0.0001) [mean difference: 2.3; 95% C.I.: 1.5 to 3], which was ameliorated 
in Tlr9-/- mice (n=8) (p=0.0006) [mean difference: -1.6; 95% C.I.: -2.4 to -0.83]. (b) 
Following NH4-Ac stimulation, there was a significant increase in the intracellular cytokine 
TNF-alpha produced by splenic macrophages in WT mice (n=8) compared to controls (n=7) 
(p<0.0001) [mean difference: 25; 95% C.I.: 22 to 28.5], which was ameliorated in Tlr9-/- mice 
(n=8) (p<0.0001) [mean difference: -14; 95% C.I.: -17.2 to -10.8]. (c) Following NH4-Ac 
stimulation, there was a significant increase in the intracellular cytokine IL-6 produced by 
splenic macrophages in WT mice (n=8) compared to controls (n=7) (p<0.0001) [mean 
difference: 4; 95% C.I.: 3.5 to 4.5], which was ameliorated in Tlr9-/- mice (n=8) (p<0.0001) 
[mean difference: -4; 95% C.I.: -4.7 to -3.5]. (d) Representative FACS plots of intracellular 
cytokines IFN-gamma, TNF-alpha and IL-6 produced by splenic macrophages in WT mice 
and Tlr9-/- mice controls, and following NH4-Ac stimulation. 
Figure 3: Ammonia-induced intracellular cytokine production by T cells is mediated by 
TLR9. 
(a) Following NH4-Ac stimulation, there was a significant increase in the intracellular 
cytokine IFN-gamma produced by splenic CD4+ T cells in WT mice compared to controls 
(p<0.0001) [median difference: 2.7; 95% C.I.: 1.5 to 3], which was ameliorated in Tlr9-/- 
mice compared to WT mice (p=0.0007) [median difference: -1.9; 95% C.I.: -2.8 to -0.8]. (b) 
Following NH4-Ac stimulation, there was a significant increase in the intracellular cytokine 
TNF-alpha produced by splenic CD4+ T cells in WT mice compared to controls (p<0.0001) 
[mean difference: 49.5; 95% C.I.: 47 to 52], which was ameliorated in Tlr9-/- mice compared 
to WT mice (p<0.0001) [mean difference: -27.5; 95% C.I.: -30 to -25]. (c) Following NH4-Ac 
stimulation, there was a significant increase in the intracellular cytokine IL-6 produced by 
splenic CD4+ T cells in WT mice compared to controls (p<0.0001) [mean difference: 2.2; 
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95% C.I.: 1.4 to 3], which was ameliorated in Tlr9-/- mice compared to WT mice (p=0.0052) 
[mean difference: -1.6; 95% C.I.: -2.7 to -0.5]. (d) Following NH4-Ac stimulation, there was 
a significant increase in the intracellular cytokine IFN-gamma produced by splenic CD8+ T 
cells in WT mice compared to controls (p=0.0002) [mean difference: 3.9; 95% C.I.: 2.1 to 
5.8], which was ameliorated in Tlr9-/- mice compared to WT mice (p=0.0003) [median 
difference: -3.5; 95% C.I.: -6.4 to -2.1]. (e) Following NH4-Ac stimulation, there was a 
significant increase in the intracellular cytokine TNF-alpha produced by splenic CD8+ T cells 
in WT mice compared to controls (p<0.0001) [mean difference: 49; 95% C.I.: 46 to 52], 
which was ameliorated in Tlr9-/- mice compared to WT- mice (p<0.0001) [mean difference: -
48; 95% C.I.: -51 to -45]. (f) Representative FACS plots of the intracellular cytokines IFN-
gamma, TNF-alpha and IL-6 produced by splenic T cells in WT mice and Tlr9-/- mice 
controls and following NH4-Ac stimulation. [WT mice controls (n=11) & NH4-Ac treated 
(n=13); Tlr9-/- mice controls (n=10) & NH4-Ac treated (n=10)]. 
Figure 4: Ammonia-induced intracellular cytokine production by liver infiltrated T cells. 
(a) Following NH4-Ac stimulation, there was a significant increase in the intracellular 
cytokine IFN-gamma produced by liver infiltrated CD4+ T cells in WT mice compared to 
controls (p<0.0001) [median difference: 18.3; 95% C.I.: 15 to 21.6], which was ameliorated 
in Tlr9-/- mice compared to WT mice (p<0.0001) [median difference: -14.5; 95% C.I.: -18.6 
to -10.3]. (b) Following NH4-Ac stimulation, there was a significant increase in the 
intracellular cytokine TNF-alpha produced by liver infiltrated CD4+ T cells in WT mice 
compared to controls (p<0.0001) [mean difference: 21.4; 95% C.I.: 14.5 to 28.2], which was 
ameliorated in Tlr9-/- mice compared to WT mice (p<0.0001) [mean difference: -20; 95% 
C.I.: -27 to -12.7]. (c) Following NH4-Ac stimulation, there was a significant increase in the 
intracellular cytokine IL-6 produced by liver infiltrated CD4+ T cells in WT mice compared 
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to controls (p<0.0001) [mean difference: 11.9; 95% C.I.: 8.1 to 15.6], which was ameliorated 
in Tlr9-/- mice compared to WT mice (p=0.0082) [mean difference: -7.3; 95% C.I.: -12.4 to -
2.2]. (d) Following NH4-Ac stimulation, there was a significant increase in the intracellular 
cytokine IFN-gamma produced by liver infiltrated CD8+ T cells in WT mice compared to 
controls (p<0.0001) [mean difference: 18.3; 95% C.I.: 15.8 to 20.9], which was ameliorated 
in Tlr9-/- mice compared to WT mice (p<0.0001) [median difference: -12.4; 95% C.I.: -16.7 
to -8.2]. (e) Following NH4-Ac stimulation, there was a significant increase in the 
intracellular cytokine TNF-alpha produced by liver infiltrated CD8+ T cells in WT mice 
compared to controls (p<0.0001) [mean difference: 47.3; 95% C.I.: 39 to 56], which was 
ameliorated in Tlr9-/- mice compared to WT- mice (p<0.0001) [mean difference: -44; 95% 
C.I.: -56 to -32]. [WT mice controls (n=10) & NH4-Ac treated (n=10); Tlr9-/- mice controls 
(n=4) & NH4-Ac treated (n=7)]. 
Figure 5: Neutrophil phagocytosis measured by dextran FITC using flow cytometry in WT 
and Tlr9-/- mice after NH4-Ac stimulation. 
Following NH4-Ac stimulation, there was no difference in the mean fluorescence intensity of 
dextran FITC in neutrophils isolated from whole blood in WT mice or Tlr9-/- mice compared 
to controls. 
Figure 6: Unaltered brain edema and intracellular cytokine production by macrophages 
after Na-Ac stimulation. 
(a) Following Na-Ac stimulation, BW content remained unaltered in WT mice (n=7) 
compared to controls (n=12), but was significantly reduced compared to the NH4-Ac 
stimulated WT mice (n=9) (p<0.001) [mean difference: -1.1; 95% C.I.: -1.7 to -0.47]. (b) 
Following Na-Ac stimulation, liver bodyweight ratio remained unaltered in WT mice (n=7) 
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compared to controls (n=13), but was significantly reduced compared to the NH4-Ac 
stimulated WT mice (n=16) (p<0.001) [mean difference: -0.02; 95% C.I.: -0.028 to -0.012]. 
Following Na-Ac stimulation, the intracellular cytokine (c) IFN-gamma (p<0.0001) [mean 
difference: -2.2; 95% C.I.: -3 to -1.4], (d) TNF-alpha (p<0.0001) [mean difference: -22.3; 
95% C.I.: -28.3 to -16.3], and (e) IL-6 (p<0.0001) [mean difference: -4.5; 95% C.I.: -5.2 to -
3.9] produced by splenic macrophages were significantly reduced in WT mice (n=7) 
compared to the NH4-Ac stimulated WT mice (n=8) but remained unaltered compared to 
controls (n=7). (f) Representative FACS plots of the intracellular cytokines IFN-gamma, 
TNF-alpha and IL-6 produced by splenic macrophages in WT mice controls, NH4-Ac 
stimulated WT mice and Na-Ac stimulated WT mice. 
Figure 7: TLR9 in lysosomal expressed cells stimulates ammonia-induced brain edema 
and cytokine production by macrophages. 
(a) Following NH4-Ac stimulation, BW content was significantly ameliorated in Tlr9-/- mice 
(n=10) (p<0.05) [mean difference: -0.76; 95% C.I.: -1.5 to -0.06] and Lysm-Cre Tlr9fl/fl mice 
(n=9) (p<0.001) [mean difference: -1.4; 95% C.I.: -2 to -0.7] compared to WT mice (n=9). 
(b) Following NH4-Ac stimulation, liver bodyweight ratio was significantly ameliorated in 
Tlr9-/- mice (n=11) (p<0.0001) [mean difference: -0.015; 95% C.I.: -0.021 to -0.008] and 
Lysm-Cre Tlr9fl/fl mice (n=10) (p<0.0001) [mean difference: -0.019; 95% C.I.: -0.026 to -
0.013] compared to WT mice (n=16). (c) Following NH4-Ac stimulation, there was a 
significant increase in the hepatocyte swelling in the liver histology (H&E stained – 200x 
magnifications) in WT mice compared to Tlr9-/- mice and Lysm-Cre Tlr9fl/fl mice, where the 
cytoplasm of cells remained intact. The images in the black box inset are the representative 
images at 400x magnification. (d) Following NH4-Ac stimulation, the intracellular cytokine 
IFN-gamma produced by splenic macrophages was significantly ameliorated in Tlr9-/- mice 
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(n=8) (p<0.0001) [mean difference: -1.6; 95% C.I.: -2.4 to -0.84] and Lysm-Cre Tlr9fl/fl mice 
(n=9) (p<0.01) [mean difference: -1; 95% C.I.: -1.75 to -0.25] compared to WT mice (n=8). 
(e) Following NH4-Ac stimulation, the intracellular cytokine TNF-alpha produced by splenic 
macrophages was significantly ameliorated in Tlr9-/- mice (n=8) (p<0.0001) [mean difference: 
-14; 95% C.I.: -17.4 to -10.6] and Lysm-Cre Tlr9fl/fl mice (n=9) (p<0.0001) [mean difference: 
-11.7; 95% C.I.: -15 to -8.4] compared to WT mice (n=8). (f) Following NH4-Ac stimulation, 
the intracellular cytokine IL-6 produced by splenic macrophages was significantly 
ameliorated in Tlr9-/- mice (n=8) (p<0.0001) [mean difference: -4.1; 95% C.I.: -4.7 to -3.4] 
and Lysm-Cre Tlr9fl/fl mice (n=9) (p<0.0001) [mean difference: -3.6; 95% C.I.: -4.2 to -3] 
compared to WT mice (n=8). (g) Representative FACS plots of the intracellular cytokines 
IFN-gamma, TNF-alpha and IL-6 produced by splenic macrophages in WT mice, Tlr9-/- mice 
and Lysm-Cre Tlr9fl/fl mice following NH4-Ac stimulation. (h) There was no difference in the 
total plasma DNA level between WT mice (n=12), Tlr9-/- mice (n=17) and Lysm-Cre Tlr9fl/fl 
mice (n=12). 
Figure 8: Ammonia-induced brain edema and cytokine production in Lysm-Cre Tlr9fl/fl 
mice compared to Tlr9fl/fl mice. 
(a) Following NH4-Ac stimulation, there was a significant increase in the BW content in 
Tlr9fl/fl mice (n=11) compared to controls (n=8) (p=0.0009) [mean difference: 1.05; 95% C.I.: 
0.5 to 1.6], which was ameliorated in Lysm-Cre Tlr9fl/fl mice (n=9) (p=0.014) [mean 
difference: -0.7; 95% C.I.: -1.2 to -0.16]. (b) Following NH4-Ac stimulation, there was a 
significant increase in the liver bodyweight ratio in Tlr9fl/fl mice (n=12) compared to controls 
(n=8) (p=0.002) [mean difference: 0.007; 95% C.I.: 0.003 to 0.015], which was ameliorated 
in Lysm-Cre Tlr9fl/fl mice (n=10) (p=0.007) [mean difference: -0.008; 95% C.I.: -0.017 to -
0.002]. (c) Following NH4-Ac stimulation, there was a significant increase in the intracellular 
28 
 
cytokine IFN-gamma produced by splenic macrophages in Tlr9fl/fl mice (n=10) compared to 
controls (n=8) (p<0.0001) [mean difference: 3.5; 95% C.I.: 2.5 to 4.5], which was 
ameliorated in Lysm-Cre Tlr9fl/fl mice (n=8) (p<0.0001) [mean difference: -3.6; 95% C.I.: -
4.6 to -2.7]. (d) Following NH4-Ac stimulation, there was a significant increase in the 
intracellular cytokine TNF-alpha produced by splenic macrophages in Tlr9fl/fl mice (n=10) 
compared to controls (n=8) (p<0.0001) [mean difference: 14.3; 95% C.I.: 10.2 to 18.3], 
which was ameliorated in Lysm-Cre Tlr9fl/fl mice (n=8) (p<0.0001) [mean difference: -13; 
95% C.I.: -16.3 to -9.7]. (e) Following NH4-Ac stimulation, there was a significant increase 
in the intracellular cytokine IL-6 produced by splenic macrophages in Tlr9fl/fl mice (n=10) 
compared to controls (n=8) (p<0.0001) [mean difference: 3; 95% C.I.: 2.5 to 3.5], which was 
ameliorated in Lysm-Cre Tlr9fl/fl mice (n=8) (p<0.0001) [mean difference: -2.7; 95% C.I.: -
3.2 to -2.2]. 
Figure 9: ODN2088 inhibits the ammonia-induced brain edema and cytokine production 
by macrophages in WT mice. 
(a) Administration of the TLR9 antagonist, ODN2088, along with NH4-Ac prevented the rise 
in BW content (n=10) (p<0.001) [mean difference: -1.07; 95% C.I.: -1.7 to -0.48] compared 
to the NH4-Ac alone stimulated mice (n=9) and there was no difference compared to controls 
(n=12). (b) Administration of ODN2088, along with NH4-Ac prevented the rise in the liver 
bodyweight ratio in WT mice (n=15) (p<0.0001) [mean difference: -0.02; 95% C.I.: -0.026 to 
-0.014] compared to the NH4-Ac alone stimulated mice (n=16) and there was no difference 
compared to controls (n=13). (c) Following NH4-Ac stimulation, there was a significant 
increase in the hepatocyte swelling in the liver histology (H&E stained – 200x 
magnifications) in WT mice compared to controls, where the cytoplasm of cells remained 
intact. Administration of ODN2088, ameliorated the hepatocyte swelling in WT mice. The 
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images in the black box inset are the representative images at 400x magnification. (d) 
Following NH4-Ac stimulation, there was a significant increase in the total plasma DNA level 
in WT mice (n=12) (p=0.02) [mean difference: 12.58; 95% C.I.: 0.5 to 5.4] and in WT mice 
administered with ODN2088 (n=16) [mean difference: 11.4; 95% C.I.: 0.6 to 5.2] compared 
to controls (n=12). There was no difference in the total plasma DNA level in NH4-Ac alone 
WT mice stimulated compared to ODN2088 treated group. (e) Administration of ODN2088, 
along with NH4-Ac prevented the rise in the intracellular cytokine IFN-gamma produced by 
splenic macrophages in WT mice (n=11) (p<0.0001) [mean difference: -2.5; 95% C.I.: -3.1 to 
-1.9] compared to the NH4-Ac alone stimulated mice (n=8) and there was no difference 
compared to controls (n=7). (f) Administration of ODN2088, along with NH4-Ac prevented 
the rise in the intracellular cytokine TNF-alpha produced by splenic macrophages in WT 
mice (n=11) (p<0.0001) [mean difference: -28.9; 95% C.I.: -32.1 to -25.6] compared to the 
NH4-Ac alone stimulated mice (n=8) and there was no difference compared to controls (n=7). 
(g) Administration of ODN2088, along with NH4-Ac prevented the rise in the intracellular 
cytokine IL-6 produced by splenic macrophages in WT mice (n=11) (p<0.0001) [mean 
difference: -5; 95% C.I.: -5.5 to -4.5] compared to the NH4-Ac alone stimulated mice (n=8) 
and there was no difference compared to controls (n=7). (h) Representative FACS plots of the 
intracellular cytokines IFN-gamma, TNF-alpha and IL-6 produced by splenic macrophages in 
WT mice controls and NH4-Ac stimulated WT mice with and without ODN2088. 
Figure 10: ODN2088 inhibits the ammonia-induced cytokine production by T cells in WT 
mice. 
Administration of the TLR9 antagonist, ODN2088, along with NH4-Ac significantly inhibited 
(a) the intracellular cytokine IFN-gamma (p<0.01) [median difference: -1.8; 95% C.I.: -2.7 to 
-0.9], (b) the intracellular cytokine TNF-alpha (p<0.05) [median difference: -26; 95% C.I.: -
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29.5 to -22] and (c) the intracellular cytokine IL-6 (p<0.001) [mean difference: -2; 95% C.I.: 
-2.8 to -1.1] produced by splenic CD4+ T cells in WT mice (n=11) compared to the NH4-Ac 
alone stimulated WT mice (n=11). ODN2088 along with NH4-Ac also significantly inhibited 
(d) the intracellular cytokine IFN-gamma (p<0.0001) [mean difference: -3.3; 95% C.I.: -5.4 
to -1.3], (e) the intracellular cytokine TNF-alpha (p<0.0001) [mean difference: -45.5; 95% 
C.I.: -49 to -42] produced by splenic CD8+ T cells in WT mice (n=11) compared to the NH4-
Ac alone stimulated WT mice (n=11). (f) Representative FACS plots of the intracellular 
cytokines IFN-gamma, TNF-alpha and IL-6 produced by splenic T cells in WT mice controls 
and NH4-Ac-stimulated WT mice with and without ODN2088. 
 










